Market by Product, Application, End-user, and Region | Forecast 2019-2028
The detailed analysis of the global neurorehabilitation device market shows that in terms of revenue, the industry is estimated to grow at a CAGR of 14.52% during the forecasting years 2019-2028. It was valued at $1476.1 million in 2019, and is expected to account for $5000.3 million by 2028.
Report scope can be customized per your requirements. Request For Customization
Neurorehabilitation
devices use a surgically implanted device for delivering mild electrical pulses
to the targeted areas of the brain. The growing prevalence of Parkinson’s
diseases, coupled with the technological advancements in devices for the
treatment of Parkinson’s diseases, is expected to drive the growth of the
global neurorehabilitation device market.
The neurorehabilitation device market is largely driven by the rising geriatric population across the globe, technological advancements in neurorehabilitation devices, and the growing incidence of neurological disorders such as stroke and Parkinson’s. Elderly people are more prone to witness a high rate of strokes. The number of people aged 60 years and above has substantially increased in recent years in most of the regions, and it is expected to keep increasing in the coming years.
The purpose
of the study is to get an outline of the neurorehabilitation device market in
terms of numerous factors. Within this report, the market definition and the
key insights regarding the neurorehabilitation device industry have been discussed.
Also, the supply chain outlook, the impact of coronavirus on the neurorehabilitation
device market, the etymology of neurorehabilitation devices, key impact
analysis, and the market attractiveness index have been studied in detail.
Market
drivers like the rise in the geriatric population, the growing emergence of
neurorehabilitation wearables & robotics, and the rising prevalence of
neurological diseases are driving the studied market growth. However, the
industry is facing restraints like the lack of a skilled workforce to help
manage & treat this condition and the high cost of treatment, which are obstructing
the industry growth.
Key
opportunities like advancements in technology and the rising incidence of
neurological disorders in developing economies can be leveraged by the industry
to reach the projected growth. However, a challenge like stringent government
regulations is being faced by this market.
Geographies covered in the neurorehabilitation device
market by region are:
• North America: United States and Canada
• Europe: Germany, Italy, Spain, United
Kingdom, Russia, France, and Rest of Europe
• Asia-Pacific: South Korea, Japan,
India, ASEAN countries, Australia and New Zealand, China, and Rest of
Asia-Pacific
• Latin America: Mexico, Brazil and Rest
of Latin America
• Middle East and Africa: Saudi Arabia,
Turkey, South Africa, United Arab Emirates, and Rest of the Middle East &
Africa
The neurorehabilitation device market has been segmented as
follows:
• By Product:
O Neuro-Robotic System
O Brain-computer Interface
O Wearable Device
O Non-invasive Stimulator
O Other Products
• By End-user:
O Hospitals/Clinic
O Research Institute
O Cognitive Care Center
O Other End-users
• By Application:
O Stroke
O Cerebral Palsy
O Parkinson’s Disease
O Multiple Sclerosis
O Other Applications
The
key players engaged in the neurorehabilitation device market are Hokoma AG,
Kinestica, Medtronic Inc, Tyromotion GmbH, Abbott Laboratories, Bioxtreme,
Bionik Laboratories Corp, Biometrics Ltd, Kinova, Neurostyle Pte Ltd, Reha
Technology AG, Saebo, Ectron Limited, Helius Medical Technologies, and Ekso
Bionics Holdings Inc.
The
strategic analysis for each of these companies has been covered in detail. The neurorehabilitation
device market by company profiles helps to dive into the information about the
key market players in this industry and how much hold they have on the market.
1. GLOBAL
NEUROREHABILITATION DEVICE MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. SUPPLY
CHAIN OUTLOOK
2.4. IMPACT
OF CORONAVIRUS ON NEUROREHABILITATION DEVICE MARKET
2.5. ETYMOLOGY
OF NEUROREHABILITATION DEVICE
2.6. KEY
IMPACT ANALYSIS
2.7. MARKET
ATTRACTIVENESS INDEX
2.8. KEY
INSIGHTS
2.9. MARKET
DRIVERS
2.9.1. RISE
IN GERIATRIC POPULATION
2.9.2. GROWING
EMERGENCE OF NEUROREHABILITATION WEARABLES AND ROBOTICS
2.9.3. RISING
PREVALENCE OF NEUROLOGICAL DISEASES
2.10.MARKET RESTRAINTS
2.10.1. LACK OF SKILLED WORKFORCE TO
TREAT AND MANAGE NEUROLOGICAL DISEASES
2.10.2. HIGH COST OF TREATMENT
2.11. MARKET OPPORTUNITIES
2.11.1. ADVANCEMENTS IN TECHNOLOGY
2.11.2. RISING INCIDENCE OF
NEUROLOGICAL DISORDERS IN DEVELOPING ECONOMIES
2.12. MARKET CHALLENGES
2.12.1. STRINGENT GOVERNMENT
REGULATIONS
3. NEUREHABILITATION
DEVICE MARKET OUTLOOK - BY PRODUCT
3.1. NEURO-ROBOTIC
SYSTEM
3.2. BRAIN-COMPUTER
INTERFACE
3.3. WEARABLE
DEVICE
3.4. NON-INVASIVE
STIMULATOR
3.5. OTHER
PRODUCTS
4. NEUREHABILITATION
DEVICE MARKET OUTLOOK - BY APPLICATION
4.1. STROKE
4.2. CEREBRAL
PALSY
4.3. PARKINSON’S
DISEASE
4.4. MULTIPLE
SCLEROSIS
4.5. OTHER
APPLICATIONS
5. NEUREHABILITATION
DEVICE MARKET OUTLOOK - BY END-USER
5.1. HOSPITAL/CLINIC
5.2. RESEARCH
INSTITUTE
5.3. COGNITIVE
CARE CENTER
5.4. OTHER
END-USER
6. NEUREHABILITATION
DEVICE MARKET – REGIONAL OUTLOOK
6.1. NORTH
AMERICA
6.1.1. MARKET
BY PRODUCT
6.1.2. MARKET
BY APPLICATION
6.1.3. MARKET
BY END-USER
6.1.4. COUNTRY
ANALYSIS
6.1.4.1.
UNITED STATES
6.1.4.2.
CANADA
6.2. EUROPE
6.2.1. MARKET
BY PRODUCT
6.2.2. MARKET
BY APPLICATION
6.2.3. MARKET
BY END-USER
6.2.4. COUNTRY
ANALYSIS
6.2.4.1.
GERMANY
6.2.4.2.
FRANCE
6.2.4.3.
UNITED KINGDOM
6.2.4.4.
ITALY
6.2.4.5.
RUSSIA
6.2.4.6.
SPAIN
6.2.4.7.
REST OF EUROPE
6.3. ASIA-PACIFIC
6.3.1. MARKET
BY PRODUCT
6.3.2. MARKET
BY APPLICATION
6.3.3. MARKET
BY END-USER
6.3.4. COUNTRY
ANALYSIS
6.3.4.1.
CHINA
6.3.4.2.
JAPAN
6.3.4.3.
AUSTRALIA & NEW ZEALAND
6.3.4.4.
INDIA
6.3.4.5.
SOUTH KOREA
6.3.4.6.
ASEAN COUNTRIES
6.3.4.7.
REST OF APAC
6.4. LATIN
AMERICA
6.4.1. MARKET
BY PRODUCT
6.4.2. MARKET
BY APPLICATION
6.4.3. MARKET
BY END-USER
6.4.4. COUNTRY
ANALYSIS
6.4.4.1.
MEXICO
6.4.4.2.
BRAZIL
6.4.4.3.
REST OF LATIN AMERICA
6.5. MIDDLE
EAST AND AFRICA
6.5.1. MARKET
BY PRODUCT
6.5.2. MARKET
BY APPLICATION
6.5.3. MARKET
BY END-USER
6.5.4. COUNTRY
ANALYSIS
6.5.4.1.
SAUDI ARABIA
6.5.4.2.
UNITED ARAB EMIRATES
6.5.4.3.
TURKEY
6.5.4.4.
SOUTH AFRICA
6.5.4.5.
REST OF MIDDLE EAST &
AFRICA
7. COMPANY
PROFILES
7.1. BIONIK
LABORATORIES CORP
7.2. TYROMOTION
GMBH
7.3. BIOXTREME
7.4. ECTRON
LIMITED
7.5. KINOVA
7.6. ABBOTT
LABORATORIES
7.7. BIOMETRICS
LTD
7.8. REHA
TECHNOLOGY AG
7.9. MEDTRONIC
INC
7.10. HELIUS MEDICAL TECHNOLOGIES
7.11. HOKOMA AG
7.12. KINESTICA
7.13.SAEBO
7.14. NEUROSTYLE PTE LTD
7.15.EKSO BIONICS HOLDINGS INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE
1 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY REGION, 2019-2028 (IN $ MILLION)
TABLE
2 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE
3 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE
4 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE
5 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY REGION, 2019-2028 (IN $ MILLION)
TABLE
6 NORTH AMERICA NEUROREHABILITATION
DEVICE MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE
7 NORTH AMERICA NEUROREHABILITATION
DEVICE MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE
8 NORTH AMERICA NEUROREHABILITATION
DEVICE MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE
9 NORTH AMERICA NEUROREHABILITATION
DEVICE MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE
10 EUROPE NEUROREHABILITATION DEVICE
MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE
11 EUROPE NEUROREHABILITATION DEVICE
MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE
12 EUROPE NEUROREHABILITATION DEVICE
MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE
13 EUROPE NEUROREHABILITATION DEVICE
MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE
14 ASIA-PACIFIC NEUROREHABILITATION
DEVICE MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE
15 ASIA-PACIFIC NEUROREHABILITATION
DEVICE MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE
16 ASIA-PACIFIC NEUROREHABILITATION
DEVICE MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE
17 ASIA-PACIFIC NEUROREHABILITATION
DEVICE MARKET, BY COUNTRY, HISTORIC YEAR 2016-2019 (IN $ MILLION)
TABLE
18 ASIA-PACIFIC NEUROREHABILITATION
DEVICE MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE
19 LATIN AMERICA NEUROREHABILITATION
DEVICE MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE
20 LATIN AMERICA NEUROREHABILITATION
DEVICE MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE
21 LATIN AMERICA NEUROREHABILITATION
DEVICE MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE
22 LATIN AMERICA NEUROREHABILITATION
DEVICE MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE
23 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY PRODUCT, 2019-2028 (IN $ MILLION)
TABLE
24 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY APPLICATION, 2019-2028 (IN $ MILLION)
TABLE
25 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY END-USER, 2019-2028 (IN $ MILLION)
TABLE
26 MIDDLE EAST AND AFRICA
NEUROREHABILITATION DEVICE MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE
1 GLOBAL NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
2 SUPPLY CHAIN OUTLOOK FOR
NEUROREHABILITATION DEVICE MARKET
FIGURE
3 ETYMOLOGY OF NEUROREHABILITATION
DEVICE MARKET
FIGURE
4 PREVALENCE OF ALZHEIMER’S DISEASE IN
THE UNITED STATES, AGE WISE, 2019 (%)
FIGURE
5 NUMBER OF GERIATRIC POPULATION, BY
REGION, (IN MILLION)
FIGURE
6 SURGING PREVALENCE OF PARKINSON’S
DISEASE GLOBALLY (IN MILLION)
FIGURE
7 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY NEURO-ROBOTIC SYSTEM, 2019-2028 (IN $ MILLION)
FIGURE
8 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY BRAIN-COMPUTER INTERFACE, 2019-2028 (IN $ MILLION)
FIGURE
9 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY WEARABLE DEVICE, 2019-2028 (IN $ MILLION)
FIGURE
10 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY NON-INVASIVE STIMULATOR, 2019-2028 (IN $ MILLION)
FIGURE
11 GLOBAL NEUROREHABILITATION DEVICE
MARKET BY, OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
FIGURE
12 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY STROKE, 2019-2028 (IN $ MILLION)
FIGURE
13 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY CEREBRAL PALSY, 2019-2028 (IN $ MILLION)
FIGURE
14 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY PARKINSON’S DISEASE, 2019-2028 (IN $ MILLION)
FIGURE
15 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY MULTIPLE SCLEROSIS, 2019-2028 (IN $ MILLION)
FIGURE
16 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
FIGURE
17 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY HOSPITAL/CLINIC, 2019-2028 (IN $ MILLION)
FIGURE
18 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY RESEARCH INSTITUTE, 2019-2028 (IN $ MILLION)
FIGURE
19 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY COGNITIVE CARE CENTER, 2019-2028 (IN $ MILLION)
FIGURE
20 GLOBAL NEUROREHABILITATION DEVICE
MARKET, BY OTHER END-USER, 2019-2028 (IN $ MILLION)
FIGURE
21 UNITED STATES NEUROREHABILITATION
DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
22 CANADA NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
23 GERMANY NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
24 FRANCE NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
25 UNITED KINGDOM NEUROREHABILITATION
DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
26 ITALY NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
27 RUSSIA NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
28 SPAIN NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
29 REST OF EUROPE NEUROREHABILITATION
DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
30 ASIA-PACIFIC NEUROREHABILITATION
DEVICE MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
FIGURE
31 CHINA NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
32 JAPAN NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
33 AUSTRALIA & NEW ZEALAND
NEUROREHABILITATION DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
34 INDIA NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
35 SOUTH KOREA NEUROREHABILITATION
DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
36 ASEAN COUNTRIES NEUROREHABILITATION
DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
37 REST OF APAC NEUROREHABILITATION
DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
38 MEXICO NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
39 BRAZIL NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
40 REST OF LATIN AMERICA
NEUROREHABILITATION DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
41 SAUDI ARABIA NEUROREHABILITATION
DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
42 UNITED ARAB EMIRATES
NEUROREHABILITATION DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
43 TURKEY NEUROREHABILITATION DEVICE
MARKET 2019-2028 (IN $ MILLION)
FIGURE
44 SOUTH AFRICA NEUROREHABILITATION
DEVICE MARKET 2019-2028 (IN $ MILLION)
FIGURE
45 REST OF MIDDLE EAST & AFRICA
NEUROREHABILITATION DEVICE MARKET 2019-2028 (IN $ MILLION)